
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
A. 510(k) Number:
k072246
B. Purpose for Submission:
New device
C. Measurand:
Quality controls for IgA, IgG, IgM; C3, C4, α1-Antitrypsin and Transferin
D. Type of Test:
Quantitative determination in automated, semi-automated, manual chemistry systems
E. Applicant:
Maine Standards Company
F. Proprietary and Established Names:
VALIDATE® SP1 Calibration Verification Test Set
G. Regulatory Information:
1. Regulation section:
21 CFR § 862.1660, Quality Control Material (Assayed and Unassayed)
2. Classification:
Class I
3. Product codes:
JJY, Multi-analyte controls, All kinds (Assayed and Unassayed)
4. Panel:
Chemistry (75)
H. Intended Use:
1. Intended use(s):
VALIDATE® SP1 Calibration Verification Test Set solutions are intended for in
vitro diagnostic use in the quantitative determination of linearity, calibration
verification and verification of reportable range in automated, semi-automated
and manual chemistry systems for the following analytes: Immunoglobulin A
(IgA), Immunoglobulin G, IgG), Immunoglobulin M (IgM), Complement C3
(C3), Complement C4 (C4), α1-Antitrypsin (AAT), and Transferrin (TRF).
2. Indication(s) for use:
Same as Intended use.
3. Special conditions for use statement(s):
For prescription only.
4. Special instrument requirements:
None
I. Device Description:
VALIDATE® SP1 Calibration Verification Test Sets are human serum materials
containing 5 levels of each of the seven analytes. Each test set consists of one bottle
(1.0 mL) each of Level 1 to Level 5.
J. Substantial Equivalence Information:
1. Predicate device name(s):
Cliniqa LiniCAL® Calibration Verifier Protein 1
1

--- Page 2 ---
Cliniqa LiniCAL® Calibration Verifier Protein 2
2. Predicate K number(s):
k031575 (IgA, IgG, IgM, C3, C4, TRF)
k031577 (AAT)
3. Comparison with predicate:
Similarities
Item Device Predicate
VALIDATE® SP1 Cliniqa LiniCAL®
Calibration Verification Calibration Verifier
Test Set Protein 1 and Protein 2
Intended Use For in vitro diagnostic use For in vitro diagnostic
in the quantitative use in the clinical
determination of linearity, laboratory to verify
calibration verification calibration and/ or assess
and verification of linearity. Five assayed
reportable range in levels are provided to
automated, semi- allow monitoring of the
automated and manual reportable range
chemistry systems
Matrix Human serum Same
Number of Levels 5 Levels Same
Packaging 1.0 mL each level Same
Format Liquid Same
Differences
Item New Device Predicate Devices
VALIDATE® SP1 Cliniqa Cliniqa
Calibration Verification LiniCAL® LiniCAL®
Test Set Calibration Calibration
Verifier Verifier
Protein 1 Protein 2
Analytes IgA, IgG, IgM, C3, C4, IgA, IgG, AAT, AAG,
AAT, and TRF IgM, C3, C4, AMG, AT3,
and TRF B2M, CER
Stability One year Opened vial: Opened vial:
14 days 14 days
Storage -10ºC to -20ºC 2 - 8ºC 2 - 8ºC
K. Standard/Guidance Document Referenced (if applicable):
CLSI EP6: Evaluation of linearity
L. Test Principle:
Not applicable
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
2

[Table 1 on page 2]
Similarities								
	Item			Device			Predicate	
			VALIDATE® SP1
Calibration Verification
Test Set			Cliniqa LiniCAL®
Calibration Verifier
Protein 1 and Protein 2		
Intended Use			For in vitro diagnostic use
in the quantitative
determination of linearity,
calibration verification
and verification of
reportable range in
automated, semi-
automated and manual
chemistry systems			For in vitro diagnostic
use in the clinical
laboratory to verify
calibration and/ or assess
linearity. Five assayed
levels are provided to
allow monitoring of the
reportable range		
Matrix			Human serum			Same		
Number of Levels			5 Levels			Same		
Packaging			1.0 mL each level			Same		
Format			Liquid			Same		

[Table 2 on page 2]
Differences									
	Item			New Device			Predicate Devices		
			VALIDATE® SP1
Calibration Verification
Test Set			Cliniqa
LiniCAL®
Calibration
Verifier
Protein 1		Cliniqa
LiniCAL®
Calibration
Verifier
Protein 2	
Analytes			IgA, IgG, IgM, C3, C4,
AAT, and TRF			IgA, IgG,
IgM, C3, C4,
and TRF		AAT, AAG,
AMG, AT3,
B2M, CER	
Stability			One year			Opened vial:
14 days		Opened vial:
14 days	
Storage			-10ºC to -20ºC			2 - 8ºC		2 - 8ºC	

--- Page 3 ---
a. Precision/Reproducibility:
Not applicable.
b. Linearity/assay reportable range:
Not applicable.
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Stability studies were performed with the acceptance criteria of >90%
recovery from date of manufacture. Stability data showed shelf life of 2.5
years for -10ºC and 5 years for -20ºC. The expiration date claim is one year
for -10 to -20ºC.
d. Detection limit:
Not applicable.
e. Analytical specificity:
Not applicable.
f. Assay cut-off:
Not applicable.
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable.
b. Matrix comparison:
Not applicable,
3. Clinical studies:
a. Clinical Sensitivity:
Not applicable.
b. Clinical specificity:
Not applicable.
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable.
4. Clinical cut-off:
Not applicable.
5. Expected values/Reference range:
Not applicable.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
3